Improving Genetic Counseling for BRCA+ Mothers
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Education and counseling, Education.
- Who it may be relevant to
- Registry conditions: Breast Cancer. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Parent Communication Study IV: Improving Genetic Counseling for BRCA+ Mothers
Overview
Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.
Interventions
- Behavioral Education and counseling
Education includes a workbook, counseling includes peer support. - Behavioral Education
Education includes a workbook.
Primary outcome measures
- Communication [Time frame: 1- and 6-months post-treatment]
Eligibility criteria
Inclusion criteria
- Mothers/primary caregivers to adolescents/young adults ages 13-24 years-old.
- Participating in genetic testing for hereditary breast cancer.
- Adequately speak/read English.
Exclusion criteria
\- Does not meet inclusion criteria.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- MedStar Georgetown University Hospital — Washington D.C.
Identifiers
NCT: NCT04258280 · 00001137